- Home
- WVVI vs GDTC Comparison
WVVI vs GDTC Comparison
Compare WVVI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- GDTC
- Stock Information
- Founded
- WVVI 1983
- GDTC 2018
- Country
- WVVI United States
- GDTC Singapore
- Employees
- WVVI N/A
- GDTC N/A
- Industry
- WVVI Beverages (Production/Distribution)
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- WVVI Consumer Staples
- GDTC Health Care
- Exchange
- WVVI Nasdaq
- GDTC Nasdaq
- Market Cap
- WVVI 28.2M
- GDTC 28.0M
- IPO Year
- WVVI N/A
- GDTC 2023
- Fundamental
- Price
- WVVI $5.60
- GDTC $2.17
- Analyst Decision
- WVVI
- GDTC Buy
- Analyst Count
- WVVI 0
- GDTC 1
- Target Price
- WVVI N/A
- GDTC $5.00
- AVG Volume (30 Days)
- WVVI 25.0K
- GDTC 5.7K
- Earning Date
- WVVI 08-12-2025
- GDTC 01-01-0001
- Dividend Yield
- WVVI N/A
- GDTC N/A
- EPS Growth
- WVVI N/A
- GDTC N/A
- EPS
- WVVI N/A
- GDTC N/A
- Revenue
- WVVI $38,520,945.00
- GDTC $368,838.00
- Revenue This Year
- WVVI N/A
- GDTC $5.37
- Revenue Next Year
- WVVI N/A
- GDTC N/A
- P/E Ratio
- WVVI N/A
- GDTC N/A
- Revenue Growth
- WVVI N/A
- GDTC N/A
- 52 Week Low
- WVVI $3.17
- GDTC $1.20
- 52 Week High
- WVVI $7.18
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- WVVI 50.10
- GDTC 47.12
- Support Level
- WVVI $5.50
- GDTC $2.07
- Resistance Level
- WVVI $5.89
- GDTC $2.34
- Average True Range (ATR)
- WVVI 0.53
- GDTC 0.10
- MACD
- WVVI 0.04
- GDTC -0.00
- Stochastic Oscillator
- WVVI 41.04
- GDTC 41.00
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.